Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2016, Article ID 9124245, 4 pages
Research Article

Spectrum of Intracerebral Hemorrhage in Children: A Report from PICU of a Resource Limited Country

1Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan
2Department of Radiology, Aga Khan University, Karachi, Pakistan
3Department of Surgery, Section of Neurosurgery, Aga Khan University, Karachi, Pakistan

Received 21 November 2015; Accepted 14 December 2015

Academic Editor: Samuel A. Tisherman

Copyright © 2016 Qalab Abbas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Intracerebral hemorrhage (ICH) in children is a rare but disabling disease that accounts for almost half cases of stroke. We report our experience of ICH in children. Retrospective review of medical records of children (1 month-16 years) admitted in Pediatric Intensive Care Unit between January 2007 and December 2014 was done. Data collected included age, gender, presentation, examination findings, neuroimaging done (CT, MRI, and angiography) management (conservative/intervention), and outcome. Results are presented as frequency and percentages. Of the total 50 patients, 58% were male and 26% were <1 year. On presentation 44% had vomiting, 42% had seizures, and GCS < 8 while 40% had altered level of consciousness. Single bleed was present in 88%, 94% had supratentorial bleed, and 32% had intraventricular extension. 72% had bleed volume of <30 mL and 8% had >60 mL. CT scan was done in 98% patients and MRI in 34%, while 6% underwent conventional angiography. 60% patients were managed conservatively, 36% underwent neurosurgical intervention, and 6% underwent radiological vascular intervention. Hematologic causes were identified in 52% patients and vascular malformations in 14% and in 26% no cause could be identified. 26% of patients expired.